Safe levels of exposure are determined through dose-response studies. Researchers identify the dose at which a substance causes no observed adverse effect (NOAEL) and the dose at which effects first appear (LOAEL). These findings help establish reference doses (RfD) or acceptable daily intakes (ADI) for humans, incorporating safety factors to account for uncertainties.
